Effect of a selective cyclooxygenase-2 inhibitor on renal scarring

European Surgical Research

Volumn 38, Issue 5, 2006, Pages 451-457

  Kucuk, Hasan Fehmi ^a,b   Bingul, Sadik Mehmet ^a   Kurt, Necmi ^a   Kaptanoglu, Levent ^a   Akyol, Huseyin ^a   Torlak, Oguzhan Aziz ^a   Colak, Elif ^a  

^a Kartal Research and Education Hospital   (Turkey)

^b NONE   (Turkey)

Author keywords

Cyclooxygenase 2 inhibitor; Rofecoxib; Scar formation

Indexed keywords

ALPHA TOCOPHEROL; ANTIINFECTIVE AGENT; CYCLOOXYGENASE 2 INHIBITOR; DAPSONE; EBSELEN; IBUPROFEN; LIPOPOLYSACCHARIDE; PENTOXIFYLLINE; PREDNISOLONE; RETINOL; ROFECOXIB; SODIUM CHLORIDE; ULINASTATIN; VIOREF;

ANIMAL EUTHANASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; ESCHERICHIA COLI; HISTOPATHOLOGY; INOCULATION; KIDNEY; KIDNEY PARENCHYMA; KIDNEY SCAR; MOUSE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; PYELONEPHRITIS; SCAR FORMATION; SPECIES COMPARISON; STATISTICAL SIGNIFICANCE; THERAPY EFFECT; TISSUE SECTION; TREATMENT OUTCOME;

ANIMALS; CICATRIX; CYCLOOXYGENASE 2 INHIBITORS; KIDNEY; LACTONES; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; PYELONEPHRITIS; SULFONES; WOUND HEALING;

EID: 33750220176     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000095088     Document Type: Article

References (47)

1. Adzick NS: Wound healing; in Sabiston DC (ed): Textbook of Surgery. Philadelphia, Saunders, 1997, pp 207-220.
2. Robson MC, Steed DL, Franz MG: Wound healing: biologic features and approaches to maximize healing trajectories. Curr Probl Surg 2001;38:61-140.
3. Cuono CB: Scars and keloids; in Jurkiewicz MJ, Krizek TJ, Ariyan S (eds): Plastic Surgery. Principles and Practice. St Louis, Mosby, 1990, vol 2, pp 1411-1428.
4. Linares HA: Hypertrophic healing. Controversies and etiopathogenic review; in Carvajal HF, Parks DH (eds): Burns in Children: Pediatric Burn Management. Chicago, Year Book Publishers, 1988, pp 348-362.
5. Robson MC, Barnett RA, Leitch IO, Hayward PG: Prevention and treatment of post-burn scars and contracture. World J Surg 1992;16:87-96.
6. Witte MB, Barbul A: General principles of wound healing. Surg Clin North Am 1997;77:509-528.
7. Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, Day R, Ferraz MB, Hawkey CJ, Hochberg MC, Kvien TK, Schmitzer TJ, VIGOR study group: comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med 2000;23:1520-1528.
8. Kavukcu S, Soylu A, Turkmen M, Sarioglu S, Buyukgebiz B, Gure A: The role of vitamin A in preventing renal scarring secondary to pyelonephritis. BJU Int 1999;83:1055-1059.
9. Yagmurlu A, Boleken ME, Ertoy D, Ozsan M, Gökcora H, Dindar H: Preventive effect of pentoxifylline on renal scarring in rat model of pyelonephritis. Urology 2003;61:1037-1041.
10. Hunt T: The physiology of wound healing. Ann Emerg Med 1988;17:1265-1273.
11. Mathes S, Abouljord M: Wound healing; in Davis J (ed): Clinical Surgery. St Louis, Mosby, 1987, pp 475-485.
12. Singer A, Clark R: Mechanisms of disease: cutaneous wound healing. N Engl J Med 1999;341:738-746.
13. Scott JE, Stansfeld JM: Ureteric reflux and kidney scarring in children. Arch Dis Child 1968;43:468-470.
14. Jakobsson B, Berg U, Svensson L: Renal scarring after acute pyelonephritis. Arch Dis Child 1994;70:111-115.
15. Glauser MP, Lyons JM, Braude AI: Prevention of chronic experimental pyelonephritis by suppression of acute suppuration. J Clin Invest 1978;61:403-407.
16. Bille J, Glauser MP: Protection against chronic pyelonephritis in rats by suppression of acute suppuration: effect of colchicine and neutropenia. J Infect Dis 1982;146:220-226.
17. Roberts JA, Kaack MB, Baskin G: Treatment of experimental pyelonephritis in the monkey. J Urol 1990;143:150-154.
18. Matsumoto T, Mizunoe Y, Sakamoto N, Kumazawa J: Suitability of colchicine and superoxide dismutase for the suppression of renal scarring following an infection with bacteria showing mannose-sensitive pili. Nephron 1990;56:130-135.
19. Tuan H, Hagemann I, Briedigkeit H, Dutz W: Experimental pyelonephritis. Route of infection, course and immunological aspects. Int Urol Nephrol 1972;4:285-295.
20. Mehrotra RM, Pande CL, Chaturvedi UC: Experimental pyelonephritis in rats. Indian J Med Res 1976;64:459-471.
21. Tadokoro H, Omori M: Etiological study of experimental pyelonephritis - intrarenal bacterial behavior in an experimental model. Nippon Jinzo Gakkai Shi 1974;16:560-568.
22. Prat V, Konickova L, Ritzerfeld W, Losse H: Experimental ascending E. coli infection of kidneys in the rat. Physiol Bohemoslov 1969;18:167-175.
23. Mohr HJ: Experimental studies on the etiology and pathogenesis of pyelonephritis. Beitr Pathol Anat 1969;138:357-376.
24. Sack K, Freiesleben H, Wohrmann W, Henkel W, Commichau R: Studies on the route of infection in experimental coli pyelonephritis. Virchows Arch A Pathol Pathol Anat 1972;355:323-332.
25. Prat V, Hatala M, Konickova L, Urbanova D: An experimental model of ascending pyelonephritis in the rabbit. Virchows Arch Pathol Anat Physiol Klin Med 1967;342:103-108.
26. Rocha H, Teles ES, de Oliveira MM, Barros M: Experimental pyelonephritis: enhancement of infection after delivery of Escherichia coli into the arterial supply of the kidney. J Infect Dis 1969;120:119-124.
27. Godley JA, Freedman LR: Experimental pyelonephritis: a comparison of temporary occlusion of renal artery and vein on susceptibility of rat kidney to infection. Yale J Biol Med 1964;36:268-278.
28. Slotki IN, Asscher AW: Prevention of scarring in experimental pyelonephritis in the rat by early antibiotic therapy. Nephron 1982;30:262-268.
29. Glauser MP, Meylan P, Bille J: The inflammatory response and tissue damage. The example of renal scars following acute renal infection. Pediatr Nephrol 1987;1:615-622.
30. Glauser MP, Lyons JM, Braude AI: Prevention of chronic experimental pyelonephritis by suppression of acute suppuration. J Clin Invest 1978;61:403-407.
31. McLorie GA, McKenna PH, Jumper BM, Churchill BM, Gilmour RF, Khoury AE: High grade vesicoureteral reflux: analysis of observational therapy. J Urol 1990;144:537-545.
32. Haraoka M, Matsumoto T, Takahashi K, Kubo S, Tanaka M, Kumazawa J: Suppression of renal scarring by prednisolone combined with ciprofloxacin in ascending pyelonephritis in rats. J Urol 1994;151:1078-1080.
33. Bennett RT, Mazzaccaro RJ, Chopra N, Melman A, Franco I: Suppression of renal inflammation with vitamins A and E in ascending pyelonephritis in rats. J Urol 1999;161:1681-1684.
34. Haraoka M, Matsumoto T, Mizunoe Y, Takahashi K, Kubo S, Koikawa Y, Tanaka M, Sakamoto Y, Sakumoto M, Nagafuji T: Effect of ebselen on renal scarring in rats following renal infection. Chemotherapy 1995;41:208-213.
35. Huang A, Palmer LS, Hom D, Anderson AE, Kushner L, Franco L: Ibuprofen combined with antibiotics suppresses renal scarring due to ascending pyelonephritis in rats. J Urol 1999;162:1396-1398.
36. Mochida O, Matsumoto T, Mizunoe Y, Sakumoto M, Abe J, Kumazawa J: Preventive effect of dapsone on renal scarring following mannose-sensitive piliated bacterial infection. Chemotherapy 1999;45:233-235.
37. Matsumoto T, Haraoka M, Mizunoe Y, Takahashi K, Kubo S, Sakumoto M, Tanaka M, Kumazawa J: Preventive effect of ulinastatin on renal scarring in rat model of pyelonephritis induced by direct or ascending infection with Serratia marcescens or Escherichia coli. Nephron 1995;69:65-70.
38. Skjeldal S, Hvaal K, Nordsletten L, Aasen AO, Reikeras O, Torvik A: Pentoxifylline reduces skeletal muscle necrosis after acute hindlimb ischemia in rats. Eur Surg Res 1994;26:94-100.
39. Mutsaers SE, Bishop JE, McGrouther G, Laurent GJ: Mechanisms of tissue repair: from wound healing to fibrosis. Int J Biochem Cell Biol 1997;29:5-17.
40. Stadelman WK, Digenis AG, Tobin GR: Physiology and healing dynamics of chronic cutaneous wounds. Am J Surg 1998;176(suppl 2A):26S-38S.
41. Vane JR, Bakhle YS, Botting RM: Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 1998;38:97-120.
42. Vane JR, Botting RM: Mechanism of action of nonsteroidal anti-inflammatory drugs. Am J Med 1998;104:2-8.
43. Seibert K, Zhang Y, Leahy K, Hauser S, Masferrer J, Isakson P: Distribution of COX-1 and COX-2 in normal and inflamed tissues. Adv Exp Med Biol 1997;400:167-170.
44. Seibert K, Masferrer J, Zhang Y, Gregory S, Olson G, Hauser S, Leahy K, Perkins W, Isakson P: Mediation of inflammation by cyclooxygenase-2. Agents Actions 1995;46(suppl):41-50.
45. Seibert K, Masferrer JL: Role of inducible cyclooxygenase (COX-2) in inflammation. Receptor 1994;4:17-23.
46. Komhoff M, Grone HJ, Klein T, Seyberth HW, Nusing RM: Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: implication for renal function. Am J Physiol 1997;272:F460-F468.
47. Warner TD, Giuliano F, Vojnovic I, Bukasa A, Mitchell JA, Vane JR: Nonsteroid drug selectivities for cyclooxygenase-1 rather than cyclooxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci USA 1999;22:96:7563-7568.